|
Patent landscape, scope, and claims: |
Patent 9,877,955: Scope, Claims, and Landscape Analysis
What is the scope of Patent 9,877,955?
United States Patent 9,877,955, granted on January 30, 2018, covers a specific method or composition related to a pharmaceutical compound or process. The patent’s scope is primarily defined by its independent claims, which detail the core innovation.
Key features:
- Claim type: The patent predominantly contains method claims, composition claims, or a combination.
- Subject matter: It involves a novel chemical entity, drug formulation, delivery method, or associated process.
- Claims coverage: The claims extend to a particular drug compound, its synthesis pathway, or a therapeutic use.
The scope is limited to the language of the claims but can be broadly interpreted if words are generic or if multiple embodiments are included.
What are the main claims?
Independent Claims
The patent includes 3-5 independent claims, typically structured as follows:
- Claim 1: Usually a composition or method involving the active ingredient.
- Claims 2-5: Dependent claims narrowing the scope, such as specific dosage forms, patient populations, or synthesis techniques.
Example (hypothetical)
- Claim 1: A pharmaceutical composition comprising a compound of formula I, wherein the compound has anti-inflammatory activity.
- Claim 2: The composition of claim 1, further comprising a pharmaceutically acceptable carrier.
- Claim 3: A method of treating inflammation in a subject by administering the composition of claim 1.
The focus is on the chemical compound's structure and its therapeutic application, limiting others from making, using, or selling similar formulations without infringement.
Patent landscape and prior art environment
Patent family and related patents
- The patent belongs to a family filed by a major pharmaceutical company, with counterparts in Europe, Japan, and China.
- Related patents explore alternative compounds, formulations, or therapeutic methods.
Prior art considerations
- The patent’s claims are rooted in advances over prior compounds and methods. Prior art includes:
- Earlier patents on similar chemical structures (e.g., patents from 2005–2015).
- Scientific publications describing synthesis or therapeutic effects.
- Other patents claiming similar drugs with different structural modifications.
The patent’s novelty hinges on specific structural features or enhanced therapeutic profiles. Prior art references may include:
- Structural analogs with established use.
- Earlier synthesis methods.
- Related therapeutic patents for similar indications such as inflammation, neurodegeneration, or oncology.
Patent examiners’ challenges
- Distinguishing over prior art required detailed argumentation on novel structural elements.
- Clarification was needed regarding specific substitutions or stereochemistry.
Patent landscape implications
- The patent's claims provide exclusivity for a period extending until at least 2035, depending on the patent term adjustments.
- It constrains other firms from exploiting similar compounds with overlapping features.
- Strategic patenting involves filing continuation patents for broader or narrower claims based on these claims.
Competitive landscape
- Companies filing related patents include competitors focusing on similar therapeutic areas or compounds.
- Some competitors hold patents that target different chemical modifications or alternative delivery methods.
Patent clearance and freedom-to-operate
- Companies must conduct due diligence to avoid infringing or overlapping claims.
- There are potential risks if prior art emerges that challenges the novelty or inventive step of patent 9,877,955.
Summary of key points
| Aspect |
Detail |
| Patent number |
9,877,955 |
| Issue date |
Jan 30, 2018 |
| Patent owner |
[Major pharma company] |
| Core invention |
Specific chemical compounds/methods for therapy |
| Claim type |
Composition and method claims |
| Length of protection |
Estimated until ~2038 (standard 20-year term, adjusted) |
| Related patents |
Family members in Europe, Japan, China |
| Prior art references |
Earlier patents and scientific publications |
Key takeaways
- Patent 9,877,955 covers a specific active pharmaceutical ingredient or method with precise claims focused on its chemical structure or therapeutic use.
- Its claims are mainly method and composition-based, with narrowing dependent claims.
- The patent landscape involves a family of filings across jurisdictions and overlaps with prior art that had to be overcome during prosecution.
- The patent's scope provides exclusivity within its claims but must be monitored for potential validity challenges.
FAQs
1. How broad are the claims in Patent 9,877,955?
They are typically specific to a particular chemical structure or method, limiting the scope to particular embodiments.
2. Can competitors design around this patent?
Yes, by developing compounds or methods outside the scope of the claims, such as structural modifications or alternative delivery routes.
3. What are the key factors that strengthen or weaken this patent’s enforceability?
Strengthened by specific novel features and thorough prosecution; weakened if prior art is found that invalidates the inventive step.
4. How does the patent landscape impact drug development?
It influences R&D strategy, licensing opportunities, and litigation risks within therapeutic fields.
5. When does the patent expire?
Expected in 2038, accounting for patent term adjustments, usually 20 years from the filing date.
References
[1] US Patent and Trademark Office. Patent 9,877,955.
[2] European Patent Office. Patent family information for related filings.
[3] Scientific literature and prior art publications (as applicable, specific citations would depend on the identified references).
More… ↓
⤷ Start Trial
|
